Cite
MLA Citation
Steven Le Gouill et al.. “Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group.” Lancet, vol. 7, no. 11, 2020, pp. e798–e807. http://access.bl.uk/ark:/81055/vdc_100113059970.0x000001